IRIS
Paoletti, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.977
AS - Asia 2.715
EU - Europa 890
SA - Sud America 508
AF - Africa 110
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.225
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.881
SG - Singapore 1.632
CN - Cina 461
BR - Brasile 421
IT - Italia 301
VN - Vietnam 241
FI - Finlandia 96
IE - Irlanda 88
HK - Hong Kong 76
DE - Germania 74
IN - India 63
GB - Regno Unito 59
FR - Francia 56
NG - Nigeria 55
CA - Canada 42
NL - Olanda 41
AR - Argentina 38
BD - Bangladesh 37
RU - Federazione Russa 29
MX - Messico 25
SE - Svezia 22
ID - Indonesia 21
TR - Turchia 21
ES - Italia 20
IQ - Iraq 20
PK - Pakistan 20
ZA - Sudafrica 20
AU - Australia 19
JP - Giappone 17
CZ - Repubblica Ceca 16
AT - Austria 13
EC - Ecuador 13
PL - Polonia 13
UA - Ucraina 13
EG - Egitto 12
MY - Malesia 12
CL - Cile 11
SA - Arabia Saudita 11
BE - Belgio 10
CO - Colombia 8
IL - Israele 8
LT - Lituania 7
NP - Nepal 7
PH - Filippine 7
KE - Kenya 6
TW - Taiwan 6
VE - Venezuela 6
AL - Albania 5
KR - Corea 5
SN - Senegal 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
DZ - Algeria 4
IR - Iran 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
MA - Marocco 4
NI - Nicaragua 4
PE - Perù 4
PT - Portogallo 4
PY - Paraguay 4
TH - Thailandia 4
BG - Bulgaria 3
CH - Svizzera 3
JM - Giamaica 3
SV - El Salvador 3
TN - Tunisia 3
AZ - Azerbaigian 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
IM - Isola di Man 1
Totale 7.214
Salva come PNG Salva come JPEG
Città #
Singapore 675
Ashburn 345
San Jose 326
The Dalles 242
Chandler 218
Shanghai 186
Dallas 145
Wilmington 139
New York 134
Helsinki 95
Boardman 93
Los Angeles 93
Beijing 87
Dublin 87
Ho Chi Minh City 80
Santa Clara 74
Hong Kong 69
San Mateo 63
Hanoi 57
Benin City 54
Milan 48
Buffalo 42
Princeton 34
Lawrence 33
Ann Arbor 29
Paris 29
São Paulo 29
Leawood 24
Naples 24
Seattle 23
Orem 21
Amsterdam 20
Council Bluffs 20
London 20
Phoenix 19
Rome 19
Belo Horizonte 14
Fairfield 14
Charlotte 12
Curitiba 12
Frankfurt am Main 12
Warsaw 12
Pune 11
Tokyo 11
Toronto 11
Assago 10
Boston 10
Brasília 10
Da Nang 10
Montreal 10
Mumbai 10
San Francisco 10
Atlanta 9
Brno 9
Cairo 9
Chennai 9
Falkenstein 9
Genoa 9
Haiphong 9
Munich 9
Parma 9
Rio de Janeiro 9
Stockholm 9
Woodbridge 9
Brooklyn 8
Corigliano Calabro 8
Hải Dương 8
Johannesburg 8
Philadelphia 8
Porto Alegre 8
Campinas 7
Chicago 7
Denver 7
Guarulhos 7
Hyderabad 7
Kuala Lumpur 7
Mexico City 7
Newark 7
Ambivere 6
Guayaquil 6
Jumet 6
Nuremberg 6
Pasadena 6
Secaucus 6
Buenos Aires 5
Can Tho 5
Cape Town 5
Dakar 5
Florence 5
Houston 5
Joinville 5
Moscow 5
Olomouc 5
Rochester 5
Sydney 5
Vienna 5
Bari 4
Bishkek 4
Brussels 4
Campo Grande 4
Totale 4.199
Salva come PNG Salva come JPEG
Nome #
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 164
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 133
Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps 132
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 119
An academic allergy unit during COVID-19 pandemic in Italy. 116
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 99
Treatable traits in chronic rhinosinusitis with nasal polyps 98
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 98
New therapeutic approaches with biological drugs for eosinophilic granulomatosis with polyangiitis 96
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 95
Asthma from immune pathogenesis to precision medicine 94
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 94
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets 87
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 86
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma 86
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 85
One year of mepolizumab. Efficacy and safety in real-life in Italy 84
Alpha1-antitrypsin deficiency and asthma 84
New drugs in early-stage clinical trials for allergic rhinitis 82
Interleukin-5 in the Pathophysiology of Severe Asthma 81
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 81
Advancing Precision Medicine in Asthma: Evolution of Treatment Outcomes 79
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 79
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 79
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 74
Validation and Qualification of Biomarkers and Their Translation Into Pathway-Specific Diagnostic Tests 74
Impact of asthma on bronchiectasis severity and risk of exacerbations 74
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 74
Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists 74
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease? 73
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 73
Immunostimulants in respiratory diseases: Focus on Pidotimod 73
Biologic drugs and allergen immunotherapy: potential allies 72
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life. 72
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 71
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 70
Allergen immunotherapy in Italy: How, when, and why—A real-world study conducted through a patient association 68
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 68
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital 66
Gastroesophageal reflux and asthma: when, how, and why 65
Small airway dysfunction and obesity in asthmatic patients: a dangerous liaison? 63
Biologics and airway remodeling in severe asthma 63
Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life Study 61
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine 59
Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control 58
SANI Clinical Remission definition: a useful tool in Severe Asthma management 57
Antibiotic use and associated factors in a large sample of hospitalised older people 57
COPD and biologic treatment: state of the art 57
Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines 56
Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas 56
Care for Patients with Type-2 Chronic Rhinosinusitis 55
Oral Immunotherapy with Standardized Peanut Extract: A Game-Changer for Peanut Allergy 55
Local Allergic Rhinitis: Lights and Shadows of a Mysterious Entity 54
Biologics in severe asthma: the role of real-world evidence from registries 54
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? 54
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI 54
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 54
Comorbid allergic rhinitis and asthma: important clinical considerations 53
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation 52
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 50
A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma 49
Use, Abuse, and Misuse of Nasal Medications: Real-Life Survey on Community Pharmacist's Perceptions 48
Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients 48
Vocal biomarkers correlate with FEV1 variations during methacholine challenge 48
Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate 48
Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by Dupilumab 48
Critical evaluation of asthma biomarkers in clinical practice 48
Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions 47
Prevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis 46
The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital 46
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 46
Real-world data: A relevant component in the framework of scientific evidence 46
Asthma severity: the patient’s point of view 45
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 45
Comparability of Asthma Control Test (ACT) scores between self and physician administered test 45
Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era 45
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysis 44
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 44
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 44
Exhaled nitric oxide in asthma: from diagnosis to management 43
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 43
Vaping effects on asthma: results from a web survey and clinical investigation 43
ARIA–Italy managing allergic rhinitis and asthma in a changing world: The role of the Pharmacist 43
Clinical remission in severe asthma: lights and shadows on an ambitious goal 43
Current treatment strategies for seasonal allergic rhinitis: where are we heading? 42
Predictive value of tissue eosinophilia for dupilumab response in chronic rhinosinusitis with nasal polyps: A retrospective monocentric study 41
Editorial comment on “Environmental influences on childhood asthma: Climate change” 41
Statistical advice provided by ChatGPT regarding an accepted article in Allergy 41
Mast Cells in Upper and Lower Airway Diseases: Sentinels in the Front Line 41
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy 41
Prediction of Clinical Response to Dupilumab for CRSwNP Based on the Amsterdam Classification of Completeness of Endoscopic Sinus Surgery (ACCESS) Score 41
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders 39
The Present and Future of Allergen Immunotherapy in Personalized Medicine 39
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 39
Questionnaire Validation: A User Guide for Allergy Research 39
The Use of Molecular Allergy Diagnosis in Anaphylaxis: a Literature Review 39
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study 39
Personalizing the approach to asthma treatment 39
Assessing Nasal Obstruction Improvement in Dupilumab-Treated Patients With Active Anterior Rhinomanometry: A Preliminary Study 38
Editorial: pharmacotherapy and evidence-based medicine section 38
Totale 6.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.407
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022191 4 1 11 41 0 0 4 29 8 22 59 12
2022/2023618 80 48 50 75 65 40 0 41 112 46 43 18
2023/2024868 76 68 164 37 34 85 72 44 21 36 72 159
2024/20251.434 69 25 28 30 38 137 77 108 254 302 161 205
2025/20263.990 484 231 229 398 209 177 1.015 226 220 281 224 296
Totale 7.370